RecruitingNCT06569394
CBD or placebo alongside cannabis use in young adults
About this title
Read the official source — NCT06569394Medication studyAges 18–25United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 25 years.
- Listed locations
- AuroraSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 9, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 200
- Sponsor
- University of Colorado, Denver
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 25 Years
- Official registry ID
- NCT06569394
- Official title
Show the full official title
A Randomized, Placebo Controlled Study of Cannabidiol in Young Adult Cannabis Users
Recruitment & locations
RecruitingAurora
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is University of Colorado, Denver, a university.
Does this study involve medication?
Yes. The study involves medication, including Broad Spectrum Cannabidiol (bsCBD) 400 mg and Placebo.
Who can participate?
Listed age limits: 18 years to 25 years.
Is this study still recruiting?
The registry lists this study as recruiting.
